Literature DB >> 27665159

Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia.

Michael A Bolen1, Ellen Brinza2, Rahul D Renapurkar3, Esther S H Kim2, Heather L Gornik2.   

Abstract

OBJECTIVES: This study sought to evaluate the diagnostic yield of a dedicated computed tomography angiography (CTA) protocol of the chest, abdomen, and pelvis in patients with fibromuscular dysplasia (FMD).
BACKGROUND: FMD is an uncommon vascular disease that may result in stenosis, dissection, or aneurysm of nearly all arterial distributions, typically affecting medium-sized arteries. Findings from the United States Registry for Fibromuscular Dysplasia have suggested the potential need to perform screening imaging of the aorta and medium branch vessels.
METHODS: A total of 113 consecutive patients enrolled in our institutional FMD registry who received a tailored CTA protocol at our institution between March 2013 and June 2015 were included in this study. Arterial phase contrast-enhanced images were obtained on a dual-source scanner using high pitch and electrocardiogram trigger. Images were analyzed by 2 readers.
RESULTS: Abnormalities including beading, aneurysm, dissection, and stenosis/occlusion were noted in aortic, renal, mesenteric, and iliac distributions. The most commonly affected vessels were the renal arteries (n = 76 [67%]), followed by the lower extremity/iliac arteries (n = 37 [32%]). Aortic abnormalities were less frequently encountered (n = 3 [3%]), including 1 case with mild dilation (4.2 cm) of the ascending aorta and 2 cases of dissection involving the descending aorta, 1 with mild dilation (4.4 cm). Incremental findings beyond those known at patient intake were commonly noted, including new areas of arterial beading (n = 55 [49%]), new aneurysms (n = 21 [19%]), and new dissections (n = 3 [3%]). Reformatted images were crucial, affecting final assessment in 56% of cases evaluated by reader 1 and 36% evaluated by reader 2.
CONCLUSIONS: Screening chest, abdomen, and pelvis CTA in patients with FMD showed substantial and incremental diagnostic yield. Reformatted images should routinely be included in imaging analysis. Abnormalities in the aorta were not common, so screening of the thoracic aorta may not be indicated.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aneurysm; arterial dissection; computed tomography angiography; fibromuscular dysplasia

Mesh:

Substances:

Year:  2016        PMID: 27665159     DOI: 10.1016/j.jcmg.2016.04.010

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  9 in total

1.  A plasma proteogenomic signature for fibromuscular dysplasia.

Authors:  Jeffrey W Olin; Antonio F Di Narzo; Valentina d'Escamard; Daniella Kadian-Dodov; Haoxiang Cheng; Adrien Georges; Annette King; Allison Thomas; Temo Barwari; Katherine C Michelis; Rihab Bouchareb; Emir Bander; Anelechi Anyanwu; Paul Stelzer; Farzan Filsoufi; Sander Florman; Mete Civelek; Stephanie Debette; Xavier Jeunemaitre; Johan L M Björkegren; Manuel Mayr; Nabila Bouatia-Naji; Ke Hao; Jason C Kovacic
Journal:  Cardiovasc Res       Date:  2020-01-01       Impact factor: 10.787

2.  Aortic Dimensions Are Larger in Patients With Fibromuscular Dysplasia.

Authors:  Arielle M Schwartz; Esther Kim; Patrick Gleason; Xiaona Li; Yi-An Ko; Bryan J Wells
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

Review 3.  Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Sharonne N Hayes; Esther S H Kim; Jacqueline Saw; David Adlam; Cynthia Arslanian-Engoren; Katherine E Economy; Santhi K Ganesh; Rajiv Gulati; Mark E Lindsay; Jennifer H Mieres; Sahar Naderi; Svati Shah; David E Thaler; Marysia S Tweet; Malissa J Wood
Journal:  Circulation       Date:  2018-02-22       Impact factor: 29.690

4.  Screening CT angiography in patients with suspected fibromuscular dysplasia: improved patient care with single-session skull vertex to pelvis coverage.

Authors:  Mostafa Abozeed; Michael A Bolen
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

5.  Extracranial Aneurysms in 2 Patients with Autosomal Recessive Polycystic Kidney Disease.

Authors:  Daniel S Elchediak; Anne Marie Cahill; Emma E Furth; Bernard S Kaplan; Erum A Hartung
Journal:  Case Rep Nephrol Dial       Date:  2017-05-02

Review 6.  Ultrasound Assessment of Extracranial Carotids and Vertebral Arteries in Acute Cerebral Ischemia.

Authors:  Klearchos Psychogios; Georgios Magoufis; Odysseas Kargiotis; Apostolos Safouris; Eleni Bakola; Maria Chondrogianni; Panagiotis Zis; Elefterios Stamboulis; Georgios Tsivgoulis
Journal:  Medicina (Kaunas)       Date:  2020-12-18       Impact factor: 2.430

7.  [Ischemic Colitis due to Fibromuscular Dysplasia Limited to the Inferior Mesenteric Artery: A Case Report].

Authors:  Jin Hee Park; Heon Ju Kwon; Kyung Seek Chang; Kyung A Kang; Mi Sung Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-06-19

8.  A Novel Recurrent COL5A1 Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia.

Authors:  Julie Richer; Hannah L Hill; Yu Wang; Min-Lee Yang; Kristina L Hunker; Jamie Lane; Susan Blackburn; Dawn M Coleman; Jonathan Eliason; Guillaume Sillon; Maria-Daniela D'Agostino; Prasad Jetty; François-Pierre Mongeon; Anne-Marie Laberge; Stephen E Ryan; Natalia Fendrikova-Mahlay; Thais Coutinho; Michael R Mathis; Matthew Zawistowski; Stanley L Hazen; Alexander E Katz; Heather L Gornik; Chad M Brummett; Goncalo Abecasis; Ingrid L Bergin; James C Stanley; Jun Z Li; Santhi K Ganesh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-17       Impact factor: 8.311

9.  A rare case report of bilateral common and internal iliac arterial fibromuscular dysplasia: Coexisted dissection, aneurysm, and stenosis.

Authors:  Luyun Fan; Wenjun Ma; Huimin Zhang; Jun Cai
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.